跳至主要内容
临床试验/CTRI/2025/03/082626
CTRI/2025/03/082626
尚未招募
2/3 期

AN OPEN LABELLED RANDOMISED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFECT OF TRIKATVADI GUGGULU IN PRAMEHA W.S.R. TO TYPE II DIABETES MELLITUS

SDM COLLEGE OF AYURVEDA, HOSPITAL AND RESEARCH CENTER1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年3月25日最近更新:

概览

阶段
2/3 期
状态
尚未招募
发起方
SDM COLLEGE OF AYURVEDA, HOSPITAL AND RESEARCH CENTER
入组人数
30
试验地点
1
主要终点
Fasting Blood Sugar Level

概览

简要总结

THIS IS A OPEN LABLE  RANDOMISED CONTROLLED INTERVENTIONAL STUDY THAT WILL CHECK THE EFFICTIVENESS OF TRIKATVADI GUGGULU IN CONTROLLING DIABETES MELLITUS ALSO COMPARE IT TO STANDARD GOKSHURADI GUGGULU AND CHECK IT ON 14 AND 28 DAYS WITH PRIMARY OUTCOMES  AS  Fasting Blood Sugar Level AND Post Prandial Blood Sugar Level, WHERE AS SECONDARY OUTCOMES AS Avila mootrata (Turbidity in urine), Pipasaadhikya (Polydipsia), Kshudaadhikya (polyphagia), Dourbalya (debility), Mukhatalushosha (dryness of oral cavity), Kara padadaha (neuropathy), Kara padasuptata (neuropathy), Shithilangata (fatigue)

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients fulfilling the following criteria:
  • Fasting blood sugar level between 126mg/dl TO 250mg/dl
  • Post prandial blood sugar level between 200mg/dl to 300mg/dl 3.Subjects who are willing to sign the consent form to participate in the research.

排除标准

  • Diabetic complications.
  • Any life-threatening disorder interfering with the treatment.
  • Pregnant and lactating women
  • Had participated in any clinical trial within 3 months of screening.

结局指标

主要结局

Fasting Blood Sugar Level

时间窗: 14 AND 28 DAYS

Post Prandial Blood Sugar Level

时间窗: 14 AND 28 DAYS

次要结局

  • Avila mootrata (Turbidity in urine)(Pipasaadhikya (Polydipsia))

研究者

发起方
SDM COLLEGE OF AYURVEDA, HOSPITAL AND RESEARCH CENTER
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Rohit gera

SDM AYURVEDIC COLLEGE, HOSPITAL AND RESEARCH CENTER

研究点 (1)

Loading locations...

相似试验